Trial Profile
An Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia Who Have a History of Suboptimal Adherence and Are Currently on Treatment With Oral Aripiprazole
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2014
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Bipolar I disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 09 Feb 2014 New trial record